AssetMark’s BioNTech BNTX Stock Holding History
Bought
Maintained
Sold
Other funds holding BNTX
AssetMark's BNTX Position: Q3 2026 in Review
AssetMark increased its BioNTech (BNTX) stake by 13% in Q3 2026, buying an estimated $1.26K and bringing the position to 112 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #2469.
AssetMark first reported a position in BNTX in Q3 2021 and has held it in 21 quarters since. The position peaked at $388K in Q4 2021. 226 funds tracked by Wall St. Rank hold BNTX as of Q3 2026.
- AssetMark held 112 shares of BioNTech worth $11K as of Q3 2026.
- AssetMark bought 13 BioNTech shares in Q3 2026, an estimated $1.26K.
- BioNTech made up ﹤0.01% of AssetMark's portfolio in Q3 2026, its #2469 holding.
- AssetMark first reported a position in BioNTech in Q3 2021 and has held it in 21 quarters since.
- AssetMark's BioNTech position peaked at $388K in Q4 2021.
- 226 funds tracked by Wall St. Rank held BioNTech as of Q3 2026.
Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.